KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Free Cash Flow (2017 - 2025)

Twist Bioscience (TWST) has disclosed Free Cash Flow for 9 consecutive years, with -$34.8 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 47.63% to -$34.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$86.9 million through Dec 2025, down 27.25% year-over-year, with the annual reading at -$75.6 million for FY2025, 9.34% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$34.8 million at Twist Bioscience, up from -$38.0 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$1.9 million in Q2 2025, with the low at -$74.8 million in Q2 2022.
  • Average Free Cash Flow over 5 years is -$34.3 million, with a median of -$30.4 million recorded in 2021.
  • The sharpest move saw Free Cash Flow tumbled 125.52% in 2022, then surged 79.87% in 2025.
  • Over 5 years, Free Cash Flow stood at -$59.4 million in 2021, then decreased by 10.87% to -$65.9 million in 2022, then soared by 62.85% to -$24.5 million in 2023, then grew by 3.74% to -$23.6 million in 2024, then tumbled by 47.63% to -$34.8 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$34.8 million, -$38.0 million, and -$1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.